ABT, WLP And UNH, Pushing Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 62 points (0.4%) at 16,880 as of Tuesday, Oct. 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,323 issues advancing vs. 662 declining with 163 unchanged.

The Health Services industry currently sits up 0.8% versus the S&P 500, which is up 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Abbott Laboratories ( ABT) is one of the companies pushing the Health Services industry lower today. As of noon trading, Abbott Laboratories is down $0.25 (-0.6%) to $41.99 on average volume. Thus far, 2.0 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 4.6 million shares. The stock has ranged in price between $41.98-$42.49 after having opened the day at $42.40 as compared to the previous trading day's close of $42.24.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Abbott Laboratories manufactures and sells health care products worldwide. Abbott Laboratories has a market cap of $63.8 billion and is part of the health care sector. Shares are up 10.8% year-to-date as of the close of trading on Monday. Currently there are 11 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Abbott Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Abbott Laboratories Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, WellPoint ( WLP) is down $1.86 (-1.6%) to $118.48 on average volume. Thus far, 1.3 million shares of WellPoint exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $117.60-$119.14 after having opened the day at $118.28 as compared to the previous trading day's close of $120.34.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $32.7 billion and is part of the health care sector. Shares are up 30.1% year-to-date as of the close of trading on Monday. Currently there are 7 analysts that rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is down $0.84 (-0.9%) to $91.29 on average volume. Thus far, 2.4 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 3.8 million shares. The stock has ranged in price between $90.36-$91.80 after having opened the day at $91.02 as compared to the previous trading day's close of $92.13.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $89.0 billion and is part of the health care sector. Shares are up 21.7% year-to-date as of the close of trading on Monday. Currently there are 15 analysts that rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Your Worst Enemy In a Bear Market Is Yourself

Your Worst Enemy In a Bear Market Is Yourself

Economist Perspective: Brexit Endgame in Sight?

Economist Perspective: Brexit Endgame in Sight?

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge